Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Prostatic Neoplasms × Magnetic Resonance Imaging × Clear all

Phase

Status

Completed 16 Terminated 4 Unknown 3 Recruiting 2 Withdrawn 1 Suspended 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1

Interventions

Fluorodeoxyglucose F18 2 enzalutamide 1 Surveys and Questionnaires 1 Specimen Handling 1 PSMA-11 1 Magnetic Resonance Imaging 1 Inosine Monophosphate 1 Genetic Testing 1 Genetic Counseling 1 Cryotherapy 1 Biopsy 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06238661 2026-03-05

ProScreenMRI

Fondazione del Piemonte per l'Oncologia

Phase NA Enrolling by invitation

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡